Recent advances in quantitative structure-activity relationship models of antimalarial drugs

被引:13
|
作者
Ojha, Probir Kumar [1 ]
Kumar, Vinay [1 ]
Roy, Joyita [1 ]
Roy, Kunal [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Drug Theoret & Cheminformat Lab, Kolkata, India
关键词
Malaria; qsar; resistance; validation; double Cross-Validation; virtual screening; MOLECULAR DOCKING; QSAR; REQUIREMENTS; DERIVATIVES; INHIBITION; REGRESSION; 2D-QSAR; 3D-QSAR; TOOL;
D O I
10.1080/17460441.2021.1866535
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Due to emerging resistance to the first-line artemisinin-based antimalarials and lack of efficient vaccines and limited chemotherapeutic alternatives, there is an urgent need to develop new antimalarial compounds. In this regard, quantitative structure-activity relationship (QSAR) modeling can provide essential information about required physicochemical properties and structural parameters of antimalarial drug candidates. Areas covered: The authors provide an overview of recent advances of QSAR models covering different classes of antimalarial compounds as well as molecular docking studies of compounds acting on different antimalarial targets reported in the last 5 years (2015-2019) to explore the mode of interactions between the molecules and the receptors. We have tried to cover most of the QSAR models of antimalarials (along with results from some other related computational methods) reported during 2015-2019. Expert opinion: Many QSAR reports for antimalarial compounds are based on small number of data points. This review infers that most of the present work deals with analog-based QSAR approach with a limited applicability domain (a very few cases with wide domain) whereas novel target-based computational approach is reported in very few cases, which leads to huge voids of computational work based on novel antimalarial targets.
引用
收藏
页码:659 / 695
页数:37
相关论文
共 50 条
  • [21] Complementary Quantitative Structure-Activity Relationship Models for the Antitrypanosomal Activity of Sesquiterpene Lactones
    Kimani, Njogu M.
    Matasyoh, Josphat C.
    Kaiser, Marcel
    Nogueira, Mauro S.
    Trossini, Gustavo H. G.
    Schmidt, Thomas J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [22] Recent advances on natural depsidones: sources, biosynthesis, structure-activity relationship, and bioactivities
    Khayat, Maan T.
    Ghazawi, Kholoud F.
    Samman, Waad A.
    Alhaddad, Aisha A.
    Mohamed, Gamal A.
    Ibrahim, Sabrin R. M.
    PEERJ, 2023, 11
  • [23] Recent advances of honokiol:pharmacological activities, manmade derivatives and structure-activity relationship
    Li, Xiuxia
    Yuan, Zhuo
    Wang, Yuxia
    Wang, Wenjing
    Shi, Jianyou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 272
  • [24] A Quantitative Structure-Activity Relationship Model
    Zahouily, Mohamed
    Lazar, Mohamed
    Bnoumarzouk, Marouan
    Mouhibi, Rokaya
    Nohair, Mohamed
    Bahlaoui, M. Abdellah
    CHEMICAL PRODUCT AND PROCESS MODELING, 2008, 3 (01):
  • [25] Development of Predictive Quantitative Structure-Activity Relationship Models of Epipodophyllotoxin Derivatives
    Naik, Pradeep Kumar
    Dubey, Abhishek
    Kumar, Rishay
    JOURNAL OF BIOMOLECULAR SCREENING, 2010, 15 (10) : 1194 - 1203
  • [26] Quantitative Structure-activity Relationship (QSAR) Models for Docking Score Correction
    Fukunishi, Yoshifumi
    Yamasaki, Satoshi
    Yasumatsu, Isao
    Takeuchi, Koh
    Kurosawa, Takashi
    Nakamura, Haruki
    MOLECULAR INFORMATICS, 2017, 36 (1-2)
  • [27] Quantum chemical descriptors in quantitative structure-activity relationship models and their applications
    Liangliang, Wang
    Junjie, Ding
    Li, Pan
    Dongsheng, Cao
    Hui, Jiang
    Xiaoqin, Ding
    CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, 2021, 217
  • [28] Quantitative structure-activity relationship models for potent DNA alkylating agents
    Hannongbua, Supa
    Saparpakorn, Patchreenart
    Kim, Jae-Hyoun
    MOLECULAR & CELLULAR TOXICOLOGY, 2009, 5 (03) : 81 - 81
  • [29] On some aspects of validation of predictive quantitative structure-activity relationship models
    Roy, Kunal
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (12) : 1567 - 1577
  • [30] In silico human and rat Vss quantitative structure-activity relationship models
    Gleeson, MP
    Waters, NJ
    Paine, SW
    Davis, AM
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) : 1953 - 1963